These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
278 related articles for article (PubMed ID: 23752272)
1. Urinary bladder cancer susceptibility markers. What do we know about functional mechanisms? Dudek AM; Grotenhuis AJ; Vermeulen SH; Kiemeney LA; Verhaegh GW Int J Mol Sci; 2013 Jun; 14(6):12346-66. PubMed ID: 23752272 [TBL] [Abstract][Full Text] [Related]
2. Genome-Wide Association Study of Bladder Cancer in a Chinese Cohort Reveals a New Susceptibility Locus at 5q12.3. Wang M; Li Z; Chu H; Lv Q; Ye D; Ding Q; Xu C; Guo J; Du M; Chen J; Song Z; Yin C; Qin C; Gu C; Zhu Y; Xia G; Liu F; Zhang Z; Yuan L; Fu G; Hu Z; Tong N; Shen J; Liu K; Sun J; Sun Y; Li J; Li X; Shen H; Xu J; Shi Y; Zhang Z Cancer Res; 2016 Jun; 76(11):3277-84. PubMed ID: 27206850 [TBL] [Abstract][Full Text] [Related]
5. Cumulative effect of genome-wide association study-identified genetic variants for bladder cancer. Wang M; Chu H; Lv Q; Wang L; Yuan L; Fu G; Tong N; Qin C; Yin C; Zhang Z; Xu J Int J Cancer; 2014 Dec; 135(11):2653-60. PubMed ID: 24740636 [TBL] [Abstract][Full Text] [Related]
6. Germline genetic markers for urinary bladder cancer risk, prognosis and treatment response. Grotenhuis AJ; Vermeulen SH; Kiemeney LA Future Oncol; 2010 Sep; 6(9):1433-60. PubMed ID: 20919828 [TBL] [Abstract][Full Text] [Related]
7. Rs11892031[A] on chromosome 2q37 in an intronic region of the UGT1A locus is associated with urinary bladder cancer risk. Selinski S; Lehmann ML; Blaszkewicz M; Ovsiannikov D; Moormann O; Guballa C; Kress A; Truss MC; Gerullis H; Otto T; Barski D; Niegisch G; Albers P; Frees S; Brenner W; Thüroff JW; Angeli-Greaves M; Seidel T; Roth G; Volkert F; Ebbinghaus R; Prager HM; Bolt HM; Falkenstein M; Zimmermann A; Klein T; Reckwitz T; Roemer HC; Hartel M; Weistenhöfer W; Schöps W; Rizvi SA; Aslam M; Bánfi G; Romics I; Ickstadt K; Hengstler JG; Golka K Arch Toxicol; 2012 Sep; 86(9):1369-78. PubMed ID: 22532026 [TBL] [Abstract][Full Text] [Related]
8. Identification of an enhancer region within the TP63/LEPREL1 locus containing genetic variants associated with bladder cancer risk. Dudek AM; Vermeulen SH; Kolev D; Grotenhuis AJ; Kiemeney LALM; Verhaegh GW Cell Oncol (Dordr); 2018 Oct; 41(5):555-568. PubMed ID: 29956121 [TBL] [Abstract][Full Text] [Related]
9. Distinct SNP combinations confer susceptibility to urinary bladder cancer in smokers and non-smokers. Schwender H; Selinski S; Blaszkewicz M; Marchan R; Ickstadt K; Golka K; Hengstler JG PLoS One; 2012; 7(12):e51880. PubMed ID: 23284801 [TBL] [Abstract][Full Text] [Related]
10. Genetic variation in PSCA is associated with bladder cancer susceptibility in a Korean population. Lee JH; Song HR; Kim HN; Kweon SS; Yun YW; Choi JS; Jung SI; Kwon DD; Kim SH; Choi YD; Shin MH Asian Pac J Cancer Prev; 2014; 15(20):8901-4. PubMed ID: 25374226 [TBL] [Abstract][Full Text] [Related]
11. Identification of a novel susceptibility locus at 13q34 and refinement of the 20p12.2 region as a multi-signal locus associated with bladder cancer risk in individuals of European ancestry. Figueroa JD; Middlebrooks CD; Banday AR; Ye Y; Garcia-Closas M; Chatterjee N; Koutros S; Kiemeney LA; Rafnar T; Bishop T; Furberg H; Matullo G; Golka K; Gago-Dominguez M; Taylor JA; Fletcher T; Siddiq A; Cortessis VK; Kooperberg C; Cussenot O; Benhamou S; Prescott J; Porru S; Dinney CP; Malats N; Baris D; Purdue MP; Jacobs EJ; Albanes D; Wang Z; Chung CC; Vermeulen SH; Aben KK; Galesloot TE; Thorleifsson G; Sulem P; Stefansson K; Kiltie AE; Harland M; Teo M; Offit K; Vijai J; Bajorin D; Kopp R; Fiorito G; Guarrera S; Sacerdote C; Selinski S; Hengstler JG; Gerullis H; Ovsiannikov D; Blaszkewicz M; Castelao JE; Calaza M; Martinez ME; Cordeiro P; Xu Z; Panduri V; Kumar R; Gurzau E; Koppova K; Bueno-De-Mesquita HB; Ljungberg B; Clavel-Chapelon F; Weiderpass E; Krogh V; Dorronsoro M; Travis RC; Tjønneland A; Brennan P; Chang-Claude J; Riboli E; Conti D; Stern MC; Pike MC; Van Den Berg D; Yuan JM; Hohensee C; Jeppson RP; Cancel-Tassin G; Roupret M; Comperat E; Turman C; De Vivo I; Giovannucci E; Hunter DJ; Kraft P; Lindstrom S; Carta A; Pavanello S; Arici C; Mastrangelo G; Kamat AM; Zhang L; Gong Y; Pu X; Hutchinson A; Burdett L; Wheeler WA; Karagas MR; Johnson A; Schned A; Monawar Hosain GM; Schwenn M; Kogevinas M; Tardón A; Serra C; Carrato A; García-Closas R; Lloreta J; Andriole G; Grubb R; Black A; Diver WR; Gapstur SM; Weinstein S; Virtamo J; Haiman CA; Landi MT; Caporaso NE; Fraumeni JF; Vineis P; Wu X; Chanock SJ; Silverman DT; Prokunina-Olsson L; Rothman N Hum Mol Genet; 2016 Mar; 25(6):1203-14. PubMed ID: 26732427 [TBL] [Abstract][Full Text] [Related]
12. Gene variants of XRCC4 and XRCC3 and their association with risk for urothelial bladder cancer. Mittal RD; Gangwar R; Mandal RK; Srivastava P; Ahirwar DK Mol Biol Rep; 2012 Feb; 39(2):1667-75. PubMed ID: 21617942 [TBL] [Abstract][Full Text] [Related]
13. Genetic variants in urinary bladder cancer: collective power of the "wimp SNPs". Golka K; Selinski S; Lehmann ML; Blaszkewicz M; Marchan R; Ickstadt K; Schwender H; Bolt HM; Hengstler JG Arch Toxicol; 2011 Jun; 85(6):539-54. PubMed ID: 21380501 [TBL] [Abstract][Full Text] [Related]
14. Alternative splicing related genetic variants contribute to bladder cancer risk. Guo Z; Zhu H; Xu W; Wang X; Liu H; Wu Y; Wang M; Chu H; Zhang Z Mol Carcinog; 2020 Aug; 59(8):923-929. PubMed ID: 32339354 [TBL] [Abstract][Full Text] [Related]
15. Do DNA repair genes OGG1, XRCC3 and XRCC7 have an impact on susceptibility to bladder cancer in the North Indian population? Gangwar R; Ahirwar D; Mandhani A; Mittal RD Mutat Res; 2009; 680(1-2):56-63. PubMed ID: 19815090 [TBL] [Abstract][Full Text] [Related]
16. Combined Genetic Biomarkers Confer Susceptibility to Risk of Urothelial Bladder Carcinoma in a Saudi Population. Elhawary NA; Nassir A; Saada H; Dannoun A; Qoqandi O; Alsharif A; Tayeb MT Dis Markers; 2017; 2017():1474560. PubMed ID: 28348449 [TBL] [Abstract][Full Text] [Related]
17. Identification of novel potential genetic predictors of urothelial bladder carcinoma susceptibility in Pakistani population. Ali SHB; Bangash KS; Rauf A; Younis M; Anwar K; Khurram R; Khawaja MA; Azam M; Qureshi AA; Akhter S; Kiemeney LA; Qamar R Fam Cancer; 2017 Oct; 16(4):577-594. PubMed ID: 28386678 [TBL] [Abstract][Full Text] [Related]
18. Urinary Molecular Pathology for Patients with Newly Diagnosed Urothelial Bladder Cancer. Zhang R; Zang J; Xie F; Zhang Y; Wang Y; Jing Y; Zhang Y; Chen Z; Shahatiaili A; Cai MC; Zhao Z; Du P; Jia S; Zhuang G; Chen H J Urol; 2021 Oct; 206(4):873-884. PubMed ID: 34061567 [TBL] [Abstract][Full Text] [Related]
19. Germline prognostic markers for urinary bladder cancer: obstacles and opportunities. Chang DW; Gu J; Wu X Urol Oncol; 2012; 30(4):524-32. PubMed ID: 22742565 [TBL] [Abstract][Full Text] [Related]
20. Mapping of the UGT1A locus identifies an uncommon coding variant that affects mRNA expression and protects from bladder cancer. Tang W; Fu YP; Figueroa JD; Malats N; Garcia-Closas M; Chatterjee N; Kogevinas M; Baris D; Thun M; Hall JL; De Vivo I; Albanes D; Porter-Gill P; Purdue MP; Burdett L; Liu L; Hutchinson A; Myers T; Tardón A; Serra C; Carrato A; Garcia-Closas R; Lloreta J; Johnson A; Schwenn M; Karagas MR; Schned A; Black A; Jacobs EJ; Diver WR; Gapstur SM; Virtamo J; Hunter DJ; Fraumeni JF; Chanock SJ; Silverman DT; Rothman N; Prokunina-Olsson L Hum Mol Genet; 2012 Apr; 21(8):1918-30. PubMed ID: 22228101 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]